The term metabolic syndrome is used for describing a cluster of cardiovascular risk factors comprising abdominal obesity, glucose intolerance=type 2 diabetes mellitus, dyslipidaemia and hypertension. A concomitant presentation of all components of the syndrome is rare, therefore, in the view of most experts three out of the four main components are sufficient for defining the syndrome. Another recently identified component of high clinical significance is the impairment of the fibrinolytic system which is now frequently mentioned in extended definitions. This clustering of metabolic risk factors has been described in various combinations and given different names including insulin resistance syndrome or syndrome X. Unfortunately, there is no generally accepted definition so far. The original mentioning of the syndrome goes back to the late sixties, when the metabolic syndrome was described as a 'disorder of genetic adaptation becoming manifest following unrestricted food intake and=or muscular inacitvity'. In its modern meaning this term was propagated by Hanefeld and Leonhardt and by Kaplan, who also called the syndrome the 'deadly quartet' to emphasize its high atherogenic potential.
Epidemiology
One consequence of the nonuniform definition is that currently available data on the frequency of the metabolic syndrome in populations are widely varying. However, it is also obvious that the syndrome is heterogenous due to differences in the genetic background of the populations studied so far. A rather plausible and frequently cited figure is that approximately 25% of the adult citizens in Western countries suffer from this syndrome. In a recent analysis of the European Group for the Study of Insulin Resistance (EGIR), the prevalence of insulin resistance, which is possibly the underlying cause and a characteristic feature of the metabolic syndrome, was reported to be approximately 16% in an European Caucasian population (Beck-Nielsen, 1999) . Nevertheless, there is agreement that better definitions as well as population-based studies are needed to obtain reliable epidemiological data.
Insulin resistance as the basis of the metabolic syndrome
It was originally hypothesized by Reaven that insulin resistance is the pathophysiological link between the metabolic disturbances of the syndrome (Reaven, 1988) . This hypothesis received rapid and growing attention. Insulin resistance is usually defined as a subnormal biological response of the body to the effect of high insulin concentrations on glucose metabolism, usually determined by the euglycaemic hyperinsulinaemic clamp technique or other methods, but may also affect lipid metabolism and is also characteristic for many hypertensive subjects. The group of Reaven and other groups published a large amount of data indicating that insulin resistance is a common feature of and possibly even the link between all facets of the metabolic syndrome (Reaven, 1988 ; Table 1 ). There is also strong evidence that an abdominal fat distribution pattern is a phenotypic characteristic of insulin resistance and the metabolic syndrome, and allows an easy and rapid visual diagnosis of subjects at elevated risk or with clinical expression of the syndrome (Hauner, 1995) . It is also obvious from the original description of Jahnke and coworkers and from many subsequent studies during the last decades that obesity is frequently the pacemaker of the clinical manifestation of the metabolic syndrome (Jahnke et al, 1969; Hanefeld and Leonhardt, 1980; Kaplan, 1989) . Moreover, both obesity and abdominal fat distribution are two independent predictors of this cluster of risk factors and have an additive if not multiplying effect.
However, it was also demonstrated that individuals exist who are not obese but who are insulin-resistant and at increased risk of developing the metabolic syndrome and premature coronary heart disease as a consequence. An interesting observation in this context is that insulin sensitivity varies threefold in lean subjects with a normal oral glucose tolerance (Hollenbeck et al, 1987) . Although it is suggestive to assume a strong genetic predisposition, lifestyle factors such as physical inactivity, unhealthy eating and modest weight gain within the normal range may contribute to the pathogenesis of many associated diseases. Therefore, the 'metabolically obese, normal-weight' individual should be treated with prudent diet and exercise before the diseases become manifest or early after onset (Ruderman et al, 1998) .
Genetics of the metabolic syndrome
There is now strong evidence to support the notion that there are families at high risk of developing the metabolic syndrome and, in particular, insulin resistance. Studies in Pima Indians have originally shown that insulin sensitivity is a familial characteristic. Within a family there is a strong resemblance between parents and their offspring, whereas a remarkable variation was found between families (Lillioja et al, 1987) . Although a variety of genetic defects have been discovered during the last decade in subjects with components of the metabolic syndrome, these abnormalities are obviously rare and may explain only a few cases or minorities of affected patients. According to a thorough analysis by Bouchard, the commonly recognized causes or risk factors of the metabolic syndrome exhibit a low to moderate heritability with the contribution of major genes for all phenotypes of the syndrome (Bouchard, 1995) . Since there are probably many genotype -environment interactions the identification of the genetic causes remains an enormous challenge for the years to come.
The metabolic syndrome and atherosclerosis
It would not be surprising that the network of independent and potent cardiovascular risk factors characteristic for the metabolic syndrome may result in an elevated risk for cardiovascular disease. Cardiovascular complications are still the leading cause of death in the developing and developed countries. However, there is only very limited information on the crucial question whether insulin resistance and=or the metabolic syndrome is associated with an increased risk of cardiovascular disease. Therefore, the before-mentioned prediction of an extraordinary atherogenic risk awaits careful evaluation. However, there are some pieces of work that may support this tempting hypothesis. In the Insulin Resistance and Atherosclerosis Study (IRAS), a cross-sectional study, the relationship between insulin sensitivity assessed by the minimal model technique and the intimal -medial thickness of the carotid artery was studied. There was a negative association between insulin sensitivity and atherosclerosis which was partially but not fully explained by traditional cardiocascular risk factors (Howard et al, 1996) . In a factor analysis to study the clustering of risk factors in the Helsinki Policemen Study it turned out that the insulin resistance factor comprising body mass index (BMI), subscapular skinfold, area under the curve of insulin and glucose, maximal O 2 uptake, mean blood pressure and triglycerides predicted the risk of coronary heart disease and stroke during the 22 y follow-up independently of other risk factors (Pyörölä et al, 2000) . In a small prospective study comprising a group of 147 individuals, insulin resistance was found to be a predictor of cardiovascular complications after a mean follow-up period of 4.7 y. Clinical endpoints developed in 13 subjects, mainly in the tertile of subjects with the greatest degree of insulin resistance (Yip et al, 1998) .
Although there is little direct evidence for an elevated atherogenic risk in subjects exhibiting the metabolic syndrome due to a lack of longitudinal clinical studies, there is additional support for this hypothesis from observational studies in subjects with type 2 diabetes. The results of these studies unequivocally demonstrate that subjects with type 2 diabetes have a 3 -7-fold elevated risk of cardiovascular death than non-diabetic subjects (Stamler et al, 1993; Haffner et al, 1998) . As expected, the risk was the higher the more cardiovascular risk factors were present in the diabetic subjects, but independent of the number of additional risk factors, presence of diabetes was associated with a 3 -4-fold elevated increase in cardiovascular mortality (Stamler et al, 1993) . As fasting insulin levels are considered to be a good correlate of whole body insulin sensitivity in subjects with normal glucose tolerance, the observation that hyperinsulinaemia represents an independent risk factor for atherosclerotic complications (Despres et al, 1996) further lends support to the concept that insulin resistance is detrimental to the cardiovascular system.
Lifestyle factors and the metabolic syndrome
There is no doubt that lifestyle factors are important determinants of insulin resistance and, thereby, the metabolic syndrome. It is crucial to identify these factors because they can be potentially modified by preventive and therapeutic (Table 2) . As this paper is focussing on the role of dietary factors, the contribution of physical activity will be only briefly addressed by quoting one recent publication. In the Insulin Resistance Atherosclerosis Study, self-reported participation in physical activity of moderate as well as vigorous intensity was associated with an improvement in insulin sensitivity assessed by frequent intravenous glucose tolerance tests. This positive relationship was independent of body weight and was associated with favourable changes of other risk factors (MayerDavis et al, 1998).
Weight gain and the metabolic syndrome
There are some recent studies which clearly indicate that weight gain is followed by development of the metabolic syndrome. In a study in children, weight gain from the age of 7.7 y to the age of 23.2 y was significantly related to serum insulin and lipids levels as well as systolic blood pressure at early adulthood (Sinaiko et al, 1999) . In a study from Finland, weight gain from early adulthood to middle age was associated with an increased risk of developing the insulin resistance syndrome. Each 5% increase in weight over a period of 30 y was associated with a nearly 200% greater risk of developing the insulin resistance syndrome, indicating the deleterious effect of weight gain since young adulthood, which is almost considered to be physiological in Western countries (Everson et al, 1998) . A matter of concern is that intensified insulin therapy in type 1 diabetes mellitus was found to be associated with clinically significant weight gain, ie a deterioration in the lipid profile and an increase in both systolic and diastolic blood pressure (Purnell et al, 1998) .
Diet and insulin sensitivity
The relationship between dietary factors and insulin sensitivity is complex and controversial. Some clinical studies have revealed adverse effects of high-fat, low-carbohydrate diets on glucose and insulin metabolism, while others did not (for review see Reaven, 1997) . One example for the complexity of the issue is the Insulin Resistance Atherosclerosis Study. In this large cohort, there was no association between fat intake within the normal variation and insulin sensitivity in non-obese subjects. However, in obese subjects with a sedentary lifestyle a high intake of dietary fats was associated with worsened insulin sensitivity. The conclusion of the authors was that this effect may be due to a mediating role of obesity in response to habitual consumption of a high-fat diet (Mayer-Davis et al, 1997). The results from epidemiological studies suggest that a high saturated fat intake is linked with glucose intolerance and other metabolic disturbances such as elevated total and LDL-cholesterol (Purnell & Brunzell, 1997) . These and other data led to the recommendation to preferentially reduce saturated fat intake for prevention of the metabolic syndrome (Riccardi & Rivellese, 2000) . A possible alternative for replacing saturated fat in the diet is by promoting a low-fat, high-carbohydrate diet. However, this recommendation is not without possible risks. Two arguments have been used against the use of high-carbohydrate diets. As pointed out by Reaven, if dietary carbohydrate intake is increased, an additional amount of insulin must be secreted to maintain glucose homeostasis. The more resistant a non-diabetic subject, the greater will be the insulin response to a high-carbohydrate diet. As long as the beta cell reserve is not exceeded, glucose concentrations can be kept normal despite compensatory elevated insulin concentrations (Reaven, 1997) . Of similar concern is the observation that low-fat, high-carbohydrate diets are associated with an elevation of fasting triglycerides and a decrease in HDLcholesterol in both normal individuals and subjects with type 2 diabetes, probably due to enhanced endogenous VLDL-triglyceride secretion, but also due to decreased lipoprotein lipase activity. In addition, the postprandial lipaemia appears to be accentuated by low-fat, high-carbohydrate diets (Reaven, 1997) .
If there are some limitations for substituting saturated fat with carbohydrates, what alternatives are available? There is now substantial evidence that replacing saturated fat with monounsaturated or polyunsaturated fat, or both, has some metabolic benefits. This replacement is even accompanied by a fall in LDL-cholesterol. A question that is not finally settled is whether substitution of saturated fat by polyunsaturated fat results in a decline in HDL-cholesterol in contrast to monounsaturated fat which appears to be neutral. However, a recent meta-analysis came to the conclusion that the changes in LDL-and HDL-cholesterol are similar when saturated fat is replaced with either carbohydrates, or monounsaturated fat, or polyunsaturated fat, or both (Gardner & Kraemer, 1995) . Thus, currently available data may allow the conclusion to be drawn that isocaloric diets high in monounsaturated fat or carbohydrates improve glucose tolerance to a similar degree in both diabetic and non-diabetic subjects Insulin resistance and the metabolic syndrome H Hauner S27 in comparison to a diet high in saturated fat (Garg, 1994; Purnell & Brunzell, 1997) .
Another interesting approach to this topic is to study the relationship between the fatty acid composition in serum and insulin sensitivity. The fatty acid pattern of serum cholesterol esters reflects rather reliably the fatty acid pattern of the diet during the preceding weeks and months. Such experiments have shown that a high insulin sensitivity in humans is associated with low proportions of palmitic acids, g-linolenic and dihomo-g-linolenic acids as well as with high proportions of linoleic acid. However, in controlled intervention studies in humans modification of the fatty acid composition of the diet was not found to significantly influence insulin sensitivity. However, one has to keep in mind that these studies were often too short and had not enough power to detect a significant effect (Vessby, 2000) .
Fibre and low glycaemic index foods
There is only a limited number of studies that looked at the effect of fibre intake on insulin sensitivity. A prominent and confirmed finding was that a low dietary fibre intake correlates with diminished insulin sensitivity in lean and obese subjects (Lovejoy and DiGirolamo, 1992) . Recent intervention studies provided some evidence for a beneficial effect of a high fibre intake. However, this improvement in insulin sensitivity was only observed with high doses of viscous soluble fibre, whereas insoluble, non-viscous cereal fibre was not found to ameliorate insulin resistance (Jenkins et al, 2000) . A high intake of soluble fibres was also found to have other favourable effects on the components of the metabolic syndrome, in particular on the lipid profile. The proposed mechanism of action is that soluble fibres slow down the rate of glucose absorption and, thereby, lower the postprandial rise in blood glucose. Similar positive effects were observed in studies where the effects of low glycaemic index foods were investigated. A high intake in low glycaemic index foods was not only associated with an improvement of insulin sensitivity, but also an improvement of other disturbances characteristic of the metabolic syndrome (Jenkins et al, 2000) .
Diet and blood pressure
High salt intake and high alcohol consumption are well known to increase blood pressure and subsequently, the risk of hypertension. In addition, increasing body weight is usually accompanied by a continuous rise in blood pressure. Therefore, current guidelines recommend weight reduction in overweight hypertensive subjects as well as reduced alcohol consumption and salt intake (Guidelines Subcommittee, 1999) . Furthermore, a recent study of the Dietary Approaches to Stop Hypertension (DASH) Collaborative Research Group demonstrated that a diet rich in fruit, vegetables, and low-fat dairy foods is able to lower both systolic and diastolic blood pressure independent of sodium reduction and weight loss (Svetkey et al, 1999) . A reduction of sodium intake in combination with the DASH diet had an additional lowering effect on blood pressure (Sacks et al, 2001) .
Intervention trials in patients with the metabolic syndrome
There are some encouraging reports from intervention trials which showed that the clinical manifestation of single components of the metabolic syndrome or of the syndrome as a whole entity can be delayed or prevented by lifestyle changes. In most of these studies specific dietary modifications were combined with recommendations to increase physical activity. For example, in a recent study from Norway, the development of the metabolic syndrome was partially reversed by a simple diet with increasing fish intake and reducing total fat intake as well as by endurance training three times a week (Torjesen et al, 1997) . The most impressive results on all metabolic risk factors and on insulin sensitivity are usually observed in obese subjects after introduction of a hypocaloric diet. Depending on the degree of weight loss there is a substantial improvement if not complete reversal of the metabolic syndrome, which indirectly emphasizes the detrimental role of obesity and its behavioural correlates (SIGN, 1996) .
Irrespective of the lack of long-term intervention studies there is indirect evidence that a lifestyle which is protective against the metabolic syndrome can favourably influence cardiovascular morbidity and mortality. A recent analysis of the Nurses' Health Study examined the role of lifestyle factors on the risk of coronary heart disease. Women of the low-risk category defined as non-smokers, with a BMI under 25 kg=m 2 , consuming at least half a drink of an alcoholic beverage per day, engaged in moderate-to-vigorous physical activity and in the highest 40% of the cohort for consumption of a diet high in cereal fibre, marine n-3 fatty acids and folate, with a high ratio of polyunsaturated to saturated fat, and low in trans-fat and glycaemic load, had a relative risk of coronary events of 0.17 as compared with all other women (Stampfer et al, 2000) . Among others, this example clearly suggests that adherence to a healthy lifestyle that includes a healthy diet, regular physical activity, and abstinence from smoking is associated with a substantially reduced risk of coronary heart disease.
Conclusion
Despite a bulk of scientific literature on the impact of lifestyle factors on the development of insulin resistance and the metabolic syndrome there is still little certainty how a diet should be composed to prevent the undesirable sequelae of atherosclerosis. A number of questions remain to be addressed and answered in the near future. Among these are: which diet is best suitable to achieve an appreciable and clinically significant improvement in insulin sensitivity?
Can an improvement in insulin sensitivity be maintained over a longer period of time? Which health benefits can be expected from a long-term dietary modification with regard to the development and course of the metabolic syndrome?
There is no doubt that there is a long way to go in obtaining convincing answers to these questions. Even if we are finally successful in clinical research settings, the greatest challenge will be how to convince people to change their lifestyle in view of the many difficulties inherent in achieving stable behavioural changes.
